IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Patterson Belknap
- Sarraf Gentile
- Andrus Anderson
- Edelson Lechtzin
- Taus Cebulash
- Krantz & Berman
- McCune Law
- Fiddler Gonzalez
- Berman Tabacco
- Lieff Cabraser
- Ahern & Associates
- Anselmi & Carvelli
- Spiro Harrison
- Skadden Arps
- Ballard Spahr
- Harkins Cunningham
- Axinn Veltrop
- Cicala Law Firm
- Burns Charest
- WilmerHale
- Armstrong Teasdale
- Norton Rose
- Levin Sedran
- Kohn Swift
- Tostrud Law Group
- Gross & Belsky
- Dilworth Paxson
- Freedman Boyd
- Girard Sharp
- Steyer Lowenthal
- Cera LLP
- Saiber LLC
- Stradley Ronon
- Lockridge Grindal
- Rosenn Jenkins
- Barrack Rodos
- Schneider Wallace
- Hach Rose Schirripa
- Cuneo Gilbert
- Welsh & Recker
- DeCotiis FitzPatrick
- Pendley Baudin
- Shapiro Arato
- Hogan Lovells
- Joseph Saveri Law Firm
- Competition Law Partners
- Sills Cummis
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Neufeld Scheck
- DiCello Levitt
- Spector Roseman
- Goldman Scarlato
- Heins Mills
- Berry Law LLC
- Seeger Weiss
- Zelle LLP
- Hunt Ortmann
- Ricci Tyrrell
- Schertler Onorato
- Fenwick & West
- Wiggin & Dana
- Faruqi & Faruqi
- Larson King
- Shinder Cantor
- Zwerling Schachter
- Rule Garza
- Lite DePalma
- Wexler Boley
- Roberts Law Firm US
- Kasowitz Benson
- Walsh Pizzi
- Boni Zack
- Obermayer Rebmann
- Dechert LLP
- Hughes Hubbard
- Kirkland & Ellis
- Lyden Chappell
- Barnes & Thornburg
- Morrison Foerster
- Segal McCambridge
- Grabar Law
- Calcaterra Pollack
- Hagens Berman
- Bonsignore Trial Lawyers
- Buchanan Ingersoll
- Napoli Shkolnik
- Carella Byrne
- McCracken Stemerman
- Wisner Baum
- Motley Rice
- Manatt Phelps
- George Feldman
- Faegre Drinker
- Bailey Duquette
- Blank Rome
- Debevoise & Plimpton
- Earp Cohn
- Goodwin Procter
- Reed Smith
- Francis Mailman
- Winston & Strawn
- Cole Schotz
- O'Melveny & Myers
- Nussbaum Law Group
- Bailey & Glasser
- White and Williams
- Venable LLP
- Baker & Hostetler
- Kaplan Fox
- Simpson Thacher & Bartlett LLP
- Steptoe LLP
- King & Spalding
- Crowell & Moring
- Gustafson Gluek
- Marks O'Neill
- Zuckerman Spaeder
- Stevens & Lee
- Cleary Gottlieb
- Tycko & Zavareei
- Arnold & Porter
- Barrett Law Group
- Dugan Law Firm
- Fox Rothschild
- Williams & Connolly
- Cozen O'Connor
- Scott&Scott
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Greenberg Traurig
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Garwin Gerstein
- Yarborough Law Firm
- Bartlit Beck
- Kelley Drye
- Morgan Lewis
- Wolf Haldenstein
- Tarter Krinsky
- Cotchett Pitre
- NastLaw
- Paul Weiss
- Lowenstein Sandler
- Baker Botts
- Lowey Dannenberg
- Boies Schiller
- Steven Williams Law
- Bingham McCutchen
- Wilson Sonsini
- Seward & Kissel
- Miller & Chevalier
- Radice Law Firm
- Whatley Kallas
- Weil Gotshal
- Cohen Milstein
- Neal & Harwell
- Robbins Geller
- Proskauer Rose
- Freshfields
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Haynes Boone
- Miller Shah
- McDermott Will & Emery
- Duane Morris
- Zimmerman Reed
- Troutman
- Lewis Brisbois
- Berger Montague
- DLA Piper
- Foley & Lardner
- Glancy Prongay
- K&L Gates
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Polsinelli PC
- Linklaters LLP
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
- White & Case
Companies
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Perrigo Co. PLC
- Impax Laboratories, Inc.
- Sandoz International GmbH
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Endo International PLC
- Aurobindo Pharma Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- Humana Inc.
- The Cigna Group
- Red Oak Sourcing LLC
- Viatris Inc.
- Hi-Tech Pharmacal Co., Inc.
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Bausch Health Cos. Inc.
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Glenmark Pharmaceuticals Ltd.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Cencora Inc.
- G&W Laboratories Inc.
- Upsher-Smith Laboratories Inc.
- McKesson Corp.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
June 10, 2021
Judge Slams Calif. For Discovery Violation In Generics MDL
A Pennsylvania federal judge overseeing a sweeping multidistrict litigation program over alleged price-fixing of generic drugs expressed frustration during a hearing Thursday as she contemplated sanctioning the California Attorney General's Office over its failure to hand over data it may rely on in building its case.
-
May 14, 2021
AGs Say High Court Ruling Doesn't Weaken Drug Price Claims
State attorneys general on Friday blasted a bid by generic-drug makers to use a recent U.S. Supreme Court ruling as a shield against the prosecutors' price-fixing claims, telling a Pennsylvania federal court that the justices' decision doesn't address the relevant law.
-
May 07, 2021
Dermatology Case Tapped As Bellwether In Generic Drug MDL
A Pennsylvania federal judge has selected a case from state enforcers over dermatology treatments to serve as a bellwether in the multidistrict litigation over price-fixing in the generic-drug industry.
-
May 05, 2021
Generic-Drug Makers Knock States' Objection To Sanctions
Generic-drug makers accused of participating in an industrywide price-fixing scheme are urging a Pennsylvania federal court to disregard state enforcers' objections to a special master's recommendation to sanction the California attorney general's office for failing to fulfill discovery obligations in the multidistrict litigation.
-
April 27, 2021
AGs Warn Against Sanctioning Calif. In Generics Pricing MDL
The attorneys general of Pennsylvania, Oregon and Minnesota urged a Pennsylvania federal judge to reject a special master's recommendation to sanction the California Attorney General's Office for failing to fulfill discovery obligations in multidistrict litigation over inflated medication prices, arguing that it has broad implications.
-
April 07, 2021
States Too Late To Question Report In MDL, Drugmakers Say
A coalition of generic-drug companies filed an opposition brief on Wednesday blasting a group of state attorneys general for contesting a special master's recommendation in sprawling multidistrict litigation accusing much of the generic-drug industry of price-fixing, arguing that the states' motion is untimely.
-
April 06, 2021
Calif. AG Says Sanctions Rec. 'Misunderstands' Generics MDL
The California Attorney General's Office said a special master went too far in recommending sanctions against it for not living up to discovery obligations in a multidistrict litigation that accuses much of the generic-drug industry of price-fixing, saying Monday all the material is coming from the defendant drugmakers and third parties.
-
March 30, 2021
Generics Cos. Argue For Heritage Bellwether In Antitrust MDL
A group of generic-drug makers facing multiple antitrust complaints for allegedly working in concert to inflate medication prices has urged a Pennsylvania federal judge to choose a case against Heritage Pharmaceuticals as the bellwether.
-
March 23, 2021
Generics MDL Special Master Says Calif. AG Merits Sanctions
A special master on Monday recommended that the California Attorney General's Office be sanctioned for failing to live up to discovery promises in the sprawling multidistrict litigation that accuses much of the generic drug industry of price-fixing, saying the office should be limited to only evidence that was produced on deadline.
-
March 17, 2021
States Push New Bellwether Generic Drug Price-Fixing Case
If a Pennsylvania federal judge wants to swap out the bellwether case in sprawling litigation that accuses much of the generic drug industry of price-fixing, a coalition of attorneys general want her to choose a different state-brought case than the one she's currently considering as a replacement.